CCPP Practice Test

Certifications > CCPP > Practice Test

CCPP Practice Test (V1)

Dive into practice questions

Question 1

A pharmacist is establishing a Collaborative Practice Agreement (CPA) with a primary care physician to manage patients with hypertension. Which of the following elements is MOST essential for the CPA to be legally valid and functional?

  1. A list of all medications the pharmacist is prohibited from prescribing.
  2. A detailed protocol outlining the specific functions and disease states the pharmacist is authorized to manage, including initiating, modifying, and discontinuing therapy.
  3. A requirement for the physician to co-sign every prescription written by the pharmacist within 24 hours.
  4. The fixed fee schedule the pharmacist will bill patients for services rendered.

Question 2

Under a CPA for anticoagulation management, a CCPP reviews a patient’s INR, which is found to be 4.5 (goal 2.0-3.0). The patient has no signs of active bleeding. According to the agreed-upon protocol, what is the pharmacist’s most appropriate action?

  1. Immediately send the patient to the emergency department without making any medication changes.
  2. Advise the patient to hold the next one to two doses of warfarin and recheck their INR in 3-5 days, while documenting the intervention.
  3. Tell the patient to continue their current warfarin dose and have the physician review the lab result.
  4. Administer oral Vitamin K 5 mg in the clinic to rapidly reverse the anticoagulation.

Question 3

A key component of successful collaborative practice is effective communication. A pharmacist working under a CPA identifies a significant drug interaction for a patient of a collaborating physician. What is the most appropriate method to communicate this finding?

  1. Leaving a note in the patient’s chart for the physician to hopefully see at the next visit.
  2. Informing the patient and instructing them to tell the physician about the interaction.
  3. Sending a secure, direct message via the electronic health record (EHR) to the physician detailing the interaction, its potential consequences, and a recommended action.
  4. Waiting until the next scheduled monthly meeting with the physician to discuss all patient issues at once.

Question 4

When a pharmacist is managing a patient’s diabetes under a CPA, which of the following activities falls outside the typical scope of such an agreement?

  1. Ordering and interpreting A1c and serum creatinine lab tests.
  2. Independently diagnosing a patient with new-onset type 2 diabetes.
  3. Initiating insulin therapy and titrating the dose based on blood glucose logs.
  4. Providing comprehensive diabetes self-management education (DSME).

Answer Key

  • Question 1: B. A detailed protocol outlining the specific functions and disease states the pharmacist is authorized to manage, including initiating, modifying, and discontinuing therapy. (The core of a CPA is the protocol that explicitly defines the pharmacist’s scope of authority, which is essential for both legal protection and clinical clarity.)
  • Question 2: B. Advise the patient to hold the next one to two doses of warfarin and recheck their INR in 3-5 days, while documenting the intervention. (This is a standard, guideline-based action for a subtherapeutic INR without bleeding that would be pre-defined in an anticoagulation CPA protocol, allowing the pharmacist to act autonomously.)
  • Question 3: C. Sending a secure, direct message via the electronic health record (EHR) to the physician detailing the interaction, its potential consequences, and a recommended action. (This method is direct, secure, timely, and creates a documented record of the communication and intervention, representing best practice for interprofessional collaboration.)
  • Question 4: B. Independently diagnosing a patient with new-onset type 2 diabetes. (Diagnosis is a function reserved for physicians or other primary care providers. A pharmacist’s role under a CPA begins after a diagnosis has been established, focusing on the management of the diagnosed condition.)